![](/img/cover-not-exists.png)
Preclinical studies of WVE-210201, an investigational stereopure antisense oligonucleotide in development for the treatment of patients with duchenne muscular dystrophy (DMD)
Panzara, M., Zhang, J., Rinaldi, C., McClorey, G., Bowman, K., Butler, D., Dodart, J., Frank-Kamenetsky, M., Iwamoto, N., Kothari, N., Lu, G., Mathieu, S., M, M., Melkonian, M., Menon, S., Standley, SVolume:
381
Language:
english
Journal:
Journal of the Neurological Sciences
DOI:
10.1016/j.jns.2017.08.791
Date:
October, 2017
File:
PDF, 368 KB
english, 2017